about
Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoeaAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.Purinergic signalling in the gastrointestinal tract and related organs in health and diseaseThe role of adenosine signaling in sickle cell therapeuticsRecent developments in adenosine receptor ligands and their potential as novel drugsDifferentiating connexin hemichannels and pannexin channels in cellular ATP release.A2B adenosine receptor gene deletion attenuates murine colitis.Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitisContributions of neutrophils to resolution of mucosal inflammation.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationThe P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.Basal release of ATP: an autocrine-paracrine mechanism for cell regulation.Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous systemLigation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell FunctionPharmacological characterization of uracil nucleotide-preferring P2Y receptors modulating intestinal motility: a study on mouse ileum.Introduction to adenosine receptors as therapeutic targets.A(₂B)AR expression in non-immune cells plays an important role in the development of murine colitisThe roles of purinergic signaling during gastrointestinal inflammation.Purinergic receptors and gastrointestinal secretomotor function.Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation.Role of adenosine A(2B) receptors in inflammation.Comparison of mechanical and electrical activity and interstitial cells of Cajal in urinary bladders from wild-type and W/Wv mice.Adenosine: an immune modulator of inflammatory bowel diseases.A(2B) adenosine receptors in immunity and inflammation.Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement.Guanosine negatively modulates the gastric motor function in mouse.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Purinergic Signalling in the Gut.Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists.Adenosine A(2A) agonist and A(2B) antagonist mediate an inhibition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation.Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells.Presynaptic inhibition of neural vasodilator pathways to submucosal arterioles by release of purines from sympathetic nerves.Purinergic signaling in the gastrointestinal tract.ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI.Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy.
P2860
Q24596978-91853D3D-0FA2-474A-ABA8-774A7C29FA1CQ24651475-F24B206A-73D9-4CC6-9025-B9BDACC1468DQ26861086-5F89997E-AC51-4A53-8D7A-89CB7B1276BEQ27010098-73E2235A-FE4B-42C9-B29B-2751EFE86443Q27687253-EC7C5BBB-B0DB-4684-8C80-77F4B9352961Q30405751-1E11960C-2FE2-43EC-8274-E6047DBA6007Q30438772-00726C41-7389-4880-A347-2A41D374A26EQ33698976-33B300C0-546A-4CC6-AD83-2F1305A73DA8Q33719500-E029B22A-B96A-4C9B-AC85-180B19F5A985Q33830064-5519B30B-7305-4C67-81D3-42636D43421EQ33846541-1123C8B3-77E6-4AF4-8075-E13CC6FABD92Q34020834-79297BA9-BBC0-4A1C-ADF0-9688C64007D1Q34981589-886F4D44-BCD5-466A-9212-3AFCF041D3B7Q35897675-32E89AFF-0E41-4FE3-B84C-54CAB568FF01Q35953958-B3791B2B-5A21-4EAF-BC83-76E5BA69FA4BQ36153376-E5CED1AE-0E2B-419B-9360-3587B9887BF6Q36218394-F11DAB5F-411C-4563-A1CD-38E82D386445Q36448977-5CAF9F25-86A9-4EE8-AC66-3902CABF3151Q36793761-AF5888D8-1C1A-48B5-A0BE-A35CDB1E3EF5Q37050910-0C8F31A6-6D1B-4802-B50B-8D9CC766C91BQ37108355-0888A54E-A507-4E6A-8B66-04C1FE742489Q37230989-E4D42AE1-00CD-4F9C-B5E8-F56C9B6ABB4CQ37362853-B371A35E-0F0F-474F-8297-A3CEF9FAE4FAQ37373680-B0EC84A0-92CB-42EB-AC9D-3F0740B9CFB2Q37404236-488C5A8F-6F48-4F54-BB58-BF16A85A98BEQ37468707-E50DF297-41B5-4589-9ECC-8DDF923DC7ADQ37957791-56BC58F7-D6EE-4F33-8588-B67F05930C5CQ38886416-272784AA-E6BC-4B3F-93FF-D4905CC04944Q39514425-847271F7-E5FE-4CC2-A047-9C43A9436279Q39600697-850E923A-75B2-44FF-91BB-4254687157FDQ42205890-C7D8C11F-576B-4932-973D-FEF09E2E44FBQ43149048-03E787D5-0725-4165-AEE7-FEF70DCFC781Q45769300-07F1E76A-9AA2-484B-84C2-6C884EC8A369Q47665974-6E850BA4-59C5-482E-950E-00C0B787253DQ48154944-2C8EF454-4B64-420E-B912-8A92522CCF0CQ48732639-62A76E91-3C32-4464-8AE7-4D2E59802337
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Purinergic receptors in gastrointestinal inflammation.
@ast
Purinergic receptors in gastrointestinal inflammation.
@en
Purinergic receptors in gastrointestinal inflammation.
@nl
type
label
Purinergic receptors in gastrointestinal inflammation.
@ast
Purinergic receptors in gastrointestinal inflammation.
@en
Purinergic receptors in gastrointestinal inflammation.
@nl
prefLabel
Purinergic receptors in gastrointestinal inflammation.
@ast
Purinergic receptors in gastrointestinal inflammation.
@en
Purinergic receptors in gastrointestinal inflammation.
@nl
P2093
P2860
P356
P1476
Purinergic receptors in gastrointestinal inflammation.
@en
P2093
Meghana Chalasani
Rahul Bajaj
Shanthi V Sitaraman
Vasantha L Kolachala
P2860
P304
P356
10.1152/AJPGI.00454.2007
P577
2007-12-06T00:00:00Z